Marketing Diagnostic Imaging to Radiologists and Health Systems
Go-to-market strategy, clinical evidence campaigns, and radiologist engagement for imaging companies — from mammography and CT to AI-assisted detection and imaging informatics.
Diagnostic Imaging Is Being Transformed by AI and Consolidation
The diagnostic imaging market is undergoing two simultaneous disruptions. First, AI-assisted detection and analysis is reshaping every modality — from mammography and chest CT to pathology and ultrasound. Second, the traditional OEM landscape is consolidating, with GE HealthCare, Siemens Healthineers, Philips, Canon Medical, and Fujifilm competing across modalities while dozens of AI startups target specific clinical workflows.
For imaging companies, the marketing challenge is layered. Capital equipment purchases involve long sales cycles and hospital-wide buying committees. AI products require a different value proposition — workflow efficiency, clinical confidence, and measurable outcomes. And in both cases, the radiologist is the clinical champion who drives adoption, even when the decision is ultimately financial.
Effective imaging marketing requires understanding these dynamics and building campaigns that address every stakeholder in the purchasing chain — from the radiologist who will use the system daily to the CFO who signs the purchase order.
How Radiologists Evaluate and Adopt New Technology
Radiology has unique adoption patterns that differ significantly from surgical specialties:
- Evidence demands are high and specific. Radiologists want to see sensitivity, specificity, false positive rates, and workflow impact data — not marketing claims. Peer-reviewed validation studies are table stakes for any serious imaging product.
- Workflow integration is a deal-breaker. A system that adds clicks, disrupts reading flow, or doesn't integrate with existing PACS won't get adopted, regardless of clinical performance. Marketing must demonstrate seamless workflow integration.
- RSNA is the center of gravity. With 50,000+ attendees, RSNA is where imaging products are launched, evaluated, and compared. Your RSNA strategy can make or break a product year. But the work begins months before the conference and continues months after.
- Economic justification is always required. Whether it's a $2 million mammography system or a $50K/year AI subscription, hospitals need ROI models. Throughput improvements, reduced callbacks, avoided biopsies, faster reporting — these are the metrics that get purchase orders signed.
INFAB: Radiation Protection Across Imaging Environments
Our long-standing work with INFAB Corporation — a leading manufacturer of radiation protection apparel — has given us direct experience marketing to radiology departments, interventional suites, and imaging centers. We've built campaigns that reach radiologists, interventional cardiologists, and radiology technologists across every imaging modality.
This includes ecommerce strategy for direct-to-facility sales, product catalog development for imaging-specific protection needs, and digital marketing campaigns that speak the language of imaging professionals. Our understanding of the imaging department ecosystem — from the reading room to the procedure suite — informs how we position products for this audience.
Services for Diagnostic Imaging Companies
AI Product Positioning
Go-to-market strategy for AI-assisted detection and analysis products. We position AI as a workflow enhancer with measurable clinical and economic impact — not a replacement for radiologists.
Capital Equipment Marketing
Multi-stakeholder campaigns for imaging systems — clinical messaging for radiologists, economic justification for administrators, and workflow demonstrations for technologists.
RSNA & Conference Strategy
End-to-end conference marketing for RSNA, ECR, HIMSS, SBI, and specialty meetings. Pre-conference demand generation, booth strategy, product demos, KOL events, and post-conference follow-up.
Clinical Evidence Campaigns
Transform published studies, FDA clearance data, and clinical validation results into campaigns that build radiologist confidence and accelerate adoption.
AI in Imaging: A Marketing Inflection Point
AI-assisted imaging is one of the fastest-moving sectors in all of medical technology. The FDA has cleared hundreds of AI algorithms for medical imaging, with mammography, chest CT, and stroke detection leading adoption. But adoption rates vary widely — not because the technology doesn't work, but because the marketing and implementation stories are often unclear.
Radiologists don't buy AI because it's AI. They buy it because it reduces their reading time, catches findings they might miss at 2 AM, or helps them manage an impossible volume of studies. Marketing AI imaging products requires translating technical performance metrics into clinical workflow stories that radiologists recognize as their daily reality.
We help AI imaging companies bridge the gap between technical capability and clinical adoption — building campaigns that address the real barriers to purchase: workflow disruption concerns, integration complexity, reimbursement uncertainty, and the fundamental question of ROI.
Imaging Segments We Serve
- Mammography & Breast Imaging — Digital mammography, 3D tomosynthesis, contrast-enhanced mammography, breast MRI, AI-assisted detection, biopsy systems
- CT & MRI — Computed tomography, magnetic resonance imaging, spectral CT, low-dose protocols, advanced visualization
- Ultrasound — Point-of-care ultrasound, 3D/4D imaging, contrast-enhanced ultrasound, AI-guided acquisition
- AI & Computer-Aided Detection — FDA-cleared algorithms for mammography, chest CT, stroke, cardiac, and pathology
- Imaging IT & PACS — Picture archiving and communication systems, enterprise imaging platforms, cloud PACS, vendor-neutral archives
- Molecular Imaging & Nuclear Medicine — PET/CT, SPECT, theranostics, radiopharmaceuticals
- Radiation Protection — Protective apparel, shielding products, dose monitoring for imaging environments
Frequently Asked Questions
What types of diagnostic imaging companies do you work with?
We work with companies across the diagnostic imaging spectrum — mammography and tomosynthesis systems, CT and MRI platforms, ultrasound devices, point-of-care diagnostics, AI-assisted detection software, PACS and imaging IT, and molecular diagnostics. Our clients range from multinational imaging OEMs to AI startups bringing new detection algorithms to market.
How do you market AI-based imaging solutions differently?
AI imaging products face unique marketing challenges — radiologists are both fascinated and skeptical, reimbursement pathways are still evolving, and FDA clearance messaging requires precision. We position AI solutions as workflow enhancers rather than replacement tools, focus on published validation data, and build campaigns around the specific clinical workflows where the AI delivers measurable improvement.
Which conferences matter most for diagnostic imaging marketing?
RSNA (Radiological Society of North America) is the dominant event with 50,000+ attendees. Other key conferences include ECR (European Congress of Radiology), HIMSS (health IT and imaging informatics), SBI (Society of Breast Imaging), AIUM (ultrasound), and specialty meetings like SNM (nuclear medicine) and ASTRO (radiation oncology). We develop conference-specific strategies for each.
Can you help with imaging product launches in the U.S. market?
Yes. We've supported U.S. market entry and product launches for imaging companies, including competitive positioning against established players, radiologist-facing messaging development, KOL engagement strategy, and launch campaigns timed to major conferences like RSNA. We also develop the economic justification materials that hospital purchasing committees require for capital imaging equipment.
Launching or Growing an Imaging Product?
We help imaging companies build campaigns that speak the language of radiology. Let's talk strategy.
Get in Touch